Download or read book Pharmaceutical Reason written by Andrew Lakoff and published by Cambridge University Press. This book was released on 2006-01-05 with total page 161 pages. Available in PDF, EPUB and Kindle. Book excerpt: Andrew Lakoff argues that a new 'pharmaceutical' way of thinking about and acting upon mental disorder is coming to reshape not only the field of psychiatry, but also our very notions of self. Drawing from a comprehensive ethnography of psychiatric practice in Argentina (a country which boasts the most psychoanalysts per capita in the world) Lakoff looks at new ways of understanding and intervening in human behaviour. He charts the globalization of pharmacology, particularily the global impact of US psychiatry and US models of illness, and further illustrates the clashes, conflicts, alliances and reformulations that take place when psychoanalytic and psychopharmacological models of illness and cure meet. Highlighting the social and political implications that these new forms of expertise about human behaviour and human thought bring, Lakoff presents an arresting case-study that will appeal to scholars and students alike.
Download or read book Pharmaceutical Freedom written by Jessica Flanigan and published by Oxford University Press. This book was released on 2017 with total page 289 pages. Available in PDF, EPUB and Kindle. Book excerpt: Jessica Flanigan defends patients' rights of self-medication on the grounds that same moral reasons against medical paternalism in clinical contexts are also reasons against paternalistic pharmaceutical policies, including prohibitive approval processes and prescription requirements.
Download or read book Building the Case for Health Literacy written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-08-26 with total page 171 pages. Available in PDF, EPUB and Kindle. Book excerpt: The field of health literacy has evolved from one focused on individuals to one that recognizes that health literacy is multidimensional. While communicating in a health literate manner is important for everyone, it is particularly important when communicating with those with limited health literacy who also experience more serious medication errors, higher rates of hospitalization and use of the emergency room, poor health outcomes, and increased mortality. Over the past decade, research has shown that health literacy interventions can significantly impact various areas including health care costs, outcomes, and health disparities. To understand the extent to which health literacy has been shown to be effective at contributing to the Quadruple Aim of improving the health of communities, providing better care, providing affordable care, and improving the experience of the health care team, the National Academies of Sciences, Engineering, and Medicine convened a public workshop on building the case for health literacy. This publication summarizes the presentations and discussions from the workshop, and highlights important lessons about the role of health literacy in meeting the Quadruple Aim, case studies of organizations that have adopted health literacy, and discussions among the different stakeholders involved in making the case for health literacy.
Download or read book Bad Pharma written by Ben Goldacre and published by Macmillan. This book was released on 2014-04 with total page 479 pages. Available in PDF, EPUB and Kindle. Book excerpt: Originally published in 2012, revised edition published in 2013, by Fourth Estate, Great Britain; Published in the United States in 2012, revised edition also, by Faber and Faber, Inc.
Download or read book Making Medicines Affordable written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2018-03-01 with total page 235 pages. Available in PDF, EPUB and Kindle. Book excerpt: Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Download or read book A Profession Without Reason written by Bruce E. Levine and published by AK Press. This book was released on 2022-06-22 with total page 216 pages. Available in PDF, EPUB and Kindle. Book excerpt: There is today a crisis in psychiatry. Even the former director of the National Institute of Mental Health, Thomas Insel, has said: “Whatever we’ve been doing for five decades, it ain’t working.” The field requires a completely fresh look, and clinical psychologist Bruce Levine—a man often at odds with his profession—enlists the early Enlightenment philosopher Baruch de Spinoza to help work through the problem. Readers unfamiliar with Spinoza will be intrigued by the modern relevance of his radical philosophical, psychological, and political ideas. Levine compares the radical/moderate divide among Enlightenment thinkers to a similar divergence between contemporary critics of psychiatry, siding historically with Spinoza in order to bring an equivalent intellectual force to bear upon our modern crisis and calling for new forms of free and enlightened thinking.
Download or read book Attrition in the Pharmaceutical Industry written by Alexander Alex and published by John Wiley & Sons. This book was released on 2015-12-02 with total page 370 pages. Available in PDF, EPUB and Kindle. Book excerpt: With a focus on case studies of R&D programs in a variety of disease areas, the book highlights fundamental productivity issues the pharmaceutical industry has been facing and explores potential ways of improving research effectiveness and efficiency. Takes a comprehensive and holistic approach to the problems and potential solutions to drug compound attrition Tackles a problem that adds billions of dollars to drug development programs and health care costs Guides discovery and development scientists through R&D stages, teaching requirements and reasons why drugs can fail Discusses potential ways forward utilizing new approaches and opportunities to reduce attrition
Download or read book Communities in Action written by National Academies of Sciences, Engineering, and Medicine and published by National Academies Press. This book was released on 2017-04-27 with total page 583 pages. Available in PDF, EPUB and Kindle. Book excerpt: In the United States, some populations suffer from far greater disparities in health than others. Those disparities are caused not only by fundamental differences in health status across segments of the population, but also because of inequities in factors that impact health status, so-called determinants of health. Only part of an individual's health status depends on his or her behavior and choice; community-wide problems like poverty, unemployment, poor education, inadequate housing, poor public transportation, interpersonal violence, and decaying neighborhoods also contribute to health inequities, as well as the historic and ongoing interplay of structures, policies, and norms that shape lives. When these factors are not optimal in a community, it does not mean they are intractable: such inequities can be mitigated by social policies that can shape health in powerful ways. Communities in Action: Pathways to Health Equity seeks to delineate the causes of and the solutions to health inequities in the United States. This report focuses on what communities can do to promote health equity, what actions are needed by the many and varied stakeholders that are part of communities or support them, as well as the root causes and structural barriers that need to be overcome.
Download or read book Why Do Drugs Cost So Much written by Joe and published by AuthorHouse. This book was released on 2008-06 with total page 430 pages. Available in PDF, EPUB and Kindle. Book excerpt: Caution! Reading this book in it's entirety may cause the following side effects: Surprise, Anger, Disbelief, and even Amusement. We begin by revealing the little known, inside workings of the pharmaceutical industry, based on the experiences of people who have worked there. Why do you think it is that your drugs cost so much? Is it because of all the high tech 'stuff' that goes into making it? Or is it something else that might shock or even anger you? What goes on behind the scenes often has nothing whatsoever to do with science. This leads to the second part which has to do with our health and the things you may not even realize are making us all sick. This is not just another 'eat right and exercise' book. You will discover information you have never heard before. There are even things that have been proven to harm you but have been covered up or ignored, and even encouraged, as long as there is money to be made. Do you like investigative reporting? Do you like history, or science fiction? Do you have a taste for the macabre? Are you concerned about declining health care, government and military cover ups, or the high cost of medicine? Written with some humor and at times a touch of sarcasm, there is a little bit of something here for everyone. You may or may not agree with some of the things in this book, but once you start reading it, your curiosity will make you want to pick it up again and again until you are finished.
Download or read book Improving and Accelerating Therapeutic Development for Nervous System Disorders written by Institute of Medicine and published by National Academies Press. This book was released on 2014-02-06 with total page 107 pages. Available in PDF, EPUB and Kindle. Book excerpt: Improving and Accelerating Therapeutic Development for Nervous System Disorders is the summary of a workshop convened by the IOM Forum on Neuroscience and Nervous System Disorders to examine opportunities to accelerate early phases of drug development for nervous system drug discovery. Workshop participants discussed challenges in neuroscience research for enabling faster entry of potential treatments into first-in-human trials, explored how new and emerging tools and technologies may improve the efficiency of research, and considered mechanisms to facilitate a more effective and efficient development pipeline. There are several challenges to the current drug development pipeline for nervous system disorders. The fundamental etiology and pathophysiology of many nervous system disorders are unknown and the brain is inaccessible to study, making it difficult to develop accurate models. Patient heterogeneity is high, disease pathology can occur years to decades before becoming clinically apparent, and diagnostic and treatment biomarkers are lacking. In addition, the lack of validated targets, limitations related to the predictive validity of animal models - the extent to which the model predicts clinical efficacy - and regulatory barriers can also impede translation and drug development for nervous system disorders. Improving and Accelerating Therapeutic Development for Nervous System Disorders identifies avenues for moving directly from cellular models to human trials, minimizing the need for animal models to test efficacy, and discusses the potential benefits and risks of such an approach. This report is a timely discussion of opportunities to improve early drug development with a focus toward preclinical trials.
Download or read book American Druggist and Pharmaceutical Record written by and published by . This book was released on 1905 with total page 428 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Quality Operations Procedures for Pharmaceutical API and Biotechnology written by Syed Imtiaz Haider and published by CRC Press. This book was released on 2012-06-06 with total page 586 pages. Available in PDF, EPUB and Kindle. Book excerpt: To stay in compliance with regulations, pharmaceutical, medical, and biotech companies must create qualtiy SOPs that build in the regulatory requirements into actions and describe personal flow, internal flow, flow of information, and processing steps. Quality Operations Procedures for Pharmaceutical, API, and Biotechnology and the accompanying CD-ROM take into account all major international regulations, such as FDA, EU GMP, cGMP, GLP, PDA technical monographs, PDA technical reports, PMA concepts, journals of PDA, GCP, and industry standard ISO 9000, to be in compliance with documentation guidelines. No other resource deals exclusively with the key elements of quality control and quality assurance procedures for pharmaceutical operations and provides hands-on templates to be tailored to achieve global regulatory compliance. The book provides instant answers about what to include in critical quality assurance and quality control SOPs and how to enhance productivity. The CD-ROM contains nineteen quality control and thirty-three quality assurance SOPs designed so that users can input them into their computers and use their Microsoft Word programs to edit and print these documents. The book ensures minimization of the number of documents, helping to reduce the nightmare-like aura that surrounds an FDA audit. The SOPs exclusively refer to the documents specially required for compliance; however, specific formats are not included to ensure that the electronic templates can be easily used by pharmaceutical, bulk pharmaceutical, medical device, and biotechnology industries. The combination of text and CD-ROM presents a ready-to-use resource on the quality systems of aseptic pharmaceutical non-aseptic production and to provide general information and guidelines. They comprise a tool that can be used to develop a set of quality SOPs in order to support the road map established for the on-time successful start-up of the facility operation in compliance with the GMP requirements.
Download or read book Pharmaceutical Landing written by Frank A. Melfa and published by . This book was released on 2005-04 with total page 150 pages. Available in PDF, EPUB and Kindle. Book excerpt: Why Not Make More Money In Pharmaceutical Sales??First You Need to Be Ready for the Interview!?Pharmaceutical Landing?s prescription for success is a must read whether you are a recent college graduate or looking to make a career change into pharmaceuticals sales. Most candidates never make it past the first interview. Learn now what managers look for during interviews. This is a straight-talking, hard-hitting guide to landing your first pharmaceutical sales job!?Learn what to bring, say, and show during the interview.?How to answer the toughest interview questions related to pharmaceutical sales.?Gain an advantage by seeing the right healthcare professionals before your interview.Do You Want to Succeed and Make $100,000 in the First Year??Then You Better Learn How to Work Smart!?Getting hired is just half the battle. Keeping your job and excelling in it is the other half. Learn how to gain a competitive edge on the rest of the 90,000 pharmaceutical reps in this country:?OUTSELL your competition by gaining access to no-see doctors and then Own their Offices!?OUTSMART by calling on the right doctors, the right amount of times using an ironclad schedule.?OUTBATTLE by learning how to present, ask questions, overcome objections, and close the sale better than the competition. Frank Melfa is a district manager for one of the largest pharmaceutical companies in the world. His uniquely successful selling and management style has helped transform poor performing territories to money-making territories. Frank is also a former champion bodybuilder and author of Bodybuilding A Realistic Approach.
Download or read book Glocal Pharma written by Ericka Johnson and published by Routledge. This book was released on 2016-05-12 with total page 134 pages. Available in PDF, EPUB and Kindle. Book excerpt: The Open Access version of this book, available at http://www.tandfebooks.com, has been made available under a Creative Commons Attribution-Non Commercial-No Derivatives 3.0 license. An exploration of how global pharmaceutical products are localized - of what happens when they become ‘glocal’ - this book examines the tensions that exist between a global pharmaceutical market and the locally bounded discourses and regulations encountered as markets are created for new drugs in particular contexts. Employing the case study of the emergence, representation and regulation of Viagra in the Swedish market, Glocal Pharma offers analyses of commercial material, medical discourses and legal documents to show how a Swedish, Viagra-consuming subject has been constructed in relation to the drug and how Viagra is imagined in relation to the Swedish man. Engaging with debates about pharmaceuticalization, the authors consider the ways in which new identities are created around drugs, the redefinition of health problems as sites of pharmaceutical treatment and changes in practices of governance to reflect the entrance of pharmaceuticals to the market. With attention to ‘local’ contexts, it reveals elements in the nexus of pharmaceutcalization that are receptive to cultural elements as new products become embedded in local markets. An empirically informed study of the the ways in which the presence of a drug can alter the concept of a disease and its treatment, understandings of who suffers from it and how to cure it - both locally and internationally - this book will appeal to scholars of sociology and science and technology studies with interests in globalization, pharmaceuticals, gender and the sociology of medicine.
Download or read book Pharmaceutical Record written by and published by . This book was released on 1891 with total page 848 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Pharmaceutical Journal written by and published by . This book was released on 1902 with total page 752 pages. Available in PDF, EPUB and Kindle. Book excerpt:
Download or read book Pharmaceutical Reason written by Andrew Lakoff and published by . This book was released on 2000 with total page 752 pages. Available in PDF, EPUB and Kindle. Book excerpt:
